• |
Additional late-stage discussions with major existing customers – In addition to the significant progress on the new light commercial vehicle program, the Company is in late-stage conversations for
two additional program expansions with existing major customers.
|
• |
Record levels of activity in the Company’s pipeline – Innoviz added an additional program to its pipeline, this time bypassing the RFI stage and moving directly to the RFQ stage. The Company also
saw multiple programs advance from the RFI to the RFQ stage during the quarter and has a record level of activity in the RFQ stage, with more than five RFQ’s currently in process.
|
• |
Potential displacement of a competitor – The Company believes that part of the reason the Company’s new light commercial vehicle program is on an accelerated timeline is because it is potentially
displacing a development-stage competitor. Furthermore, two of the Company’s advancing RFQs would possibly also displace the same development-stage competitor. Innoviz believes its 905nm solution is structurally advantaged, both in terms of
technology and cost compared to 1550nm solutions.
|
• |
In discussions with NVIDIA for Hyperion platform – Innoviz is in discussions with NVIDIA about integrating into series production programs leveraging the Hyperion platform. The conversations are
running in parallel with several of the RFIs and RFQs in the Company’s pipeline and have the potential to bring additional programs into the process.
|
• |
Innoviz is well-positioned towards 2023 Start of Production (SOP) – The Company believes that it is well-positioned for production launches of Innoviz’s BMW and shuttle programs, with volumes
expected to increase in the second half of 2023.
|
• |
Innoviz moving up the software stack, quoting new Minimum Risk Maneuver (MRM) system – MRM software and hardware acts as a failsafe to the primary autonomy system within a vehicle. In the event of a
complication with the primary system and a failure of the driver to take over steering control during a transition period, the MRM system can assume control of the vehicle and deliver it to safety, typically by exiting the road. Historically,
these have been camera-based systems. The Company is quoting both the hardware and the software for the system, offering a higher revenue and profit potential for vehicles that ultimately could include the technology. The Company also
believes that the systems could be accretive to gross margins.
|
• |
Working with 8 of the top 10 global automakers -– When combined with Innoviz’s existing customer order book, the Company has existing awards or is in an active sourcing process with eight out of the
top ten global automakers.
|
• |
An additional one to three programs with existing customers, increasing the Company’s previously announced expectations of one to two programs.
|
• |
Two series production awards with new customers.
|
• |
The new light commercial vehicle program coupled with progress on other automotive programs and new RFQs offers increased visibility into 2023 potential NRE bookings.
|
• |
Total new NRE bookings in the range of $20-40 million.
|
• |
2023 revenues in the range of $12-15 million.
|
• |
2023 Cash Collection from Customers of $20-30 million.
|
Investor Contact (US)
Rob Moffatt
VP, Corporate Development & IR
Innoviz Technologies
+1 (203) 665-8644
Investors@innoviz-tech.com
|
Investor Contact (Israel)
Maya Lustig Director, Investor Relations
Innoviz Technologies
+972 54 677 8100
Investors@innoviz-tech.com
|
Three Months Ended
March 31,
|
||||||||
2023
|
2022
|
|||||||
(Unaudited)
|
||||||||
Revenues
|
$
|
1,010
|
$
|
1,774
|
||||
Cost of revenues
|
(4,941
|
)
|
(2,431
|
)
|
||||
Gross loss
|
(3,931
|
)
|
(657
|
)
|
||||
Operating expenses:
|
||||||||
Research and development
|
26,102
|
22,761
|
||||||
Sales and marketing
|
2,448
|
2,971
|
||||||
General and administrative
|
4,735
|
5,329
|
||||||
Total operating expenses
|
33,285
|
31,061
|
||||||
Operating loss
|
(37,216
|
)
|
(31,718
|
)
|
||||
Financial income, net
|
2,776
|
1,510
|
||||||
Loss before taxes on income
|
(34,440
|
)
|
(30,208
|
)
|
||||
Taxes on income
|
(360
|
)
|
(20
|
)
|
||||
Net loss
|
$
|
(34,800
|
)
|
$
|
(30,228
|
)
|
||
Basic and diluted net loss per ordinary share
|
$
|
(0.26
|
)
|
$
|
(0.23
|
)
|
||
Weighted average number of ordinary shares used in computing basic and diluted net loss per ordinary share
|
136,358,385
|
134,224,876
|
March 31,
|
December 31,
|
|||||||
2023
|
2022
|
|||||||
|
(Unaudited)
|
|||||||
ASSETS
|
||||||||
CURRENT ASSETS:
|
||||||||
Cash and cash equivalents
|
$
|
113,381
|
$
|
55,718
|
||||
Short term restricted cash
|
53
|
236
|
||||||
Bank deposits
|
-
|
80,684
|
||||||
Marketable securities
|
35,187
|
41,681
|
||||||
Trade receivables, net
|
2,054
|
1,762
|
||||||
Inventory
|
4,133
|
4,236
|
||||||
Prepaid expenses and other current assets
|
2,976
|
3,236
|
||||||
Total current assets
|
157,784
|
187,553
|
||||||
LONG-TERM ASSETS:
|
||||||||
Marketable securities
|
7,898
|
7,840
|
||||||
Restricted deposits
|
2,535
|
2,543
|
||||||
Property and equipment, net
|
30,978
|
30,489
|
||||||
Operating lease right-of-use assets
|
27,112
|
26,927
|
||||||
Other long-term assets
|
83
|
81
|
||||||
Total long-term assets
|
68,606
|
67,880
|
||||||
Total assets
|
$
|
226,390
|
$
|
255,433
|
||||
LIABILITIES AND SHAREHOLDERS’ EQUITY
|
||||||||
CURRENT LIABILITIES:
|
||||||||
Trade payables
|
$
|
6,476
|
$
|
8,367
|
||||
Advances from customers and deferred revenues
|
4,241
|
4,082
|
||||||
Employees and payroll accruals
|
9,472
|
8,693
|
||||||
Accrued expenses and other current liabilities
|
8,574
|
7,572
|
||||||
Operating lease liabilities
|
4,744
|
3,720
|
||||||
Total current liabilities
|
33,507
|
32,434
|
||||||
LONG-TERM LIABILITIES:
|
||||||||
Advances from customers and deferred revenues
|
121
|
61
|
||||||
Operating lease liabilities
|
29,395
|
30,201
|
||||||
Warrants liability
|
712
|
720
|
||||||
Total long-term liabilities
|
30,228
|
30,982
|
||||||
SHAREHOLDERS' EQUITY:
|
||||||||
Ordinary Shares of no-par value
|
-
|
-
|
||||||
Additional paid-in capital
|
709,289
|
703,851
|
||||||
Accumulated deficit
|
(546,634
|
)
|
(511,834
|
)
|
||||
Total shareholders' equity
|
162,655
|
192,017
|
||||||
Total liabilities and shareholders' equity
|
$
|
226,390
|
$
|
255,433
|
Three Months Ended
March 31,
|
||||||||
2023
|
2022
|
|||||||
(Unaudited)
|
||||||||
Cash flows from operating activities:
|
||||||||
Net loss
|
$
|
(34,800
|
)
|
$
|
(30,228
|
)
|
||
Adjustments required to reconcile net loss to net cash used in operating activities:
|
||||||||
Depreciation and amortization
|
1,407
|
2,148
|
||||||
Remeasurement of warrants liability
|
-
|
(938
|
)
|
|||||
Change in accrued interest on bank deposits
|
1,195
|
(327
|
)
|
|||||
Change in marketable securities
|
(294
|
)
|
596
|
|||||
Share-based compensation
|
5,300
|
4,708
|
||||||
Foreign exchange gain, net
|
(89
|
)
|
(3
|
)
|
||||
Change in prepaid expenses and other assets
|
424
|
7
|
||||||
Change in trade receivables, net
|
(292
|
)
|
(591
|
)
|
||||
Changes in inventory
|
103
|
(360
|
)
|
|||||
Change in operating lease assets and liabilities, net
|
33
|
222
|
||||||
Change in trade payables
|
(1,346
|
)
|
(390
|
)
|
||||
Change in accrued expenses and other liabilities
|
762
|
(1,806
|
)
|
|||||
Change in employees and payroll accruals
|
779
|
170
|
||||||
Change in advances from customers and deferred revenues
|
219
|
84
|
||||||
Net cash used in operating activities
|
(26,599
|
)
|
(26,708
|
)
|
||||
Cash flows from investing activities:
|
||||||||
Purchase of property and equipment
|
(2,357
|
)
|
(2,406
|
)
|
||||
Investment in bank deposits
|
-
|
(5,000
|
)
|
|||||
Withdrawal of bank deposits
|
79,500
|
30,000
|
||||||
Increase in restricted deposits
|
(40
|
)
|
-
|
|||||
Investment in marketable securities
|
(7,100
|
)
|
(2,175
|
)
|
||||
Proceeds from sales and maturities of marketable securities
|
13,830
|
2,175
|
||||||
Net cash provided by investing activities
|
83,833
|
22,594
|
||||||
Cash flows from financing activities:
|
||||||||
Proceeds from exercise of options
|
120
|
88
|
||||||
Net cash provided by financing activities
|
120
|
88
|
||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
126
|
3
|
||||||
Increase (decrease) in cash, cash equivalents and restricted cash
|
57,480
|
(4,023
|
)
|
|||||
Cash, cash equivalents and restricted cash at the beginning of the period
|
55,954
|
24,541
|
||||||
Cash, cash equivalents and restricted cash at the end of the period
|
$
|
113,434
|
$
|
20,518
|